FDA Inspection
Elevate SurgicalElevate Surgical – FDA Inspection, Mar 26, 2026
Record Details
This FDA Inspection record concerns Elevate Surgical, with an inspection on March 26, 2026, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · 72b14923-519a-488a-93f0-01a8c394ed55
Inspection Facts
- Inspection number
- 1309442
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 1271.160(b)(1)Ensuring appropriate core requirements followed
- 21 CFR 1271.190(d)(1)Procedures for cleaning, sanitation
- 21 CFR 1271.200(d)Inspected routinely
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Elevate Surgical
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 27, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 1, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Elevate Surgical
- FDA Inspection 1211565 - 2023-07-27
- FDA Inspection 1064242 - 2018-08-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.